84 related articles for article (PubMed ID: 11873939)
1. Neoadjuvant treatment with docetaxel and the effects of irradiation for human ovarian adenocarcinoma and cervical squamous cell carcinoma in vitro.
Araki S; Miyagi Y; Kawanishi K; Yamamoto J; Hongo A; Kodama J; Yoshinouchi M; Kudo T
Acta Med Okayama; 2002 Feb; 56(1):13-8. PubMed ID: 11873939
[TBL] [Abstract][Full Text] [Related]
2. Association of docetaxel/paclitaxel with irradiation in ovarian carcinoma cell lines in bidimensional (sulforhodamine B assay) and tridimensional (spheroids) cultures.
Griffon-Etienne G; Merlin JL; Marchal C
Anticancer Drugs; 1996 Aug; 7(6):660-70. PubMed ID: 8913435
[TBL] [Abstract][Full Text] [Related]
3. Effects of docetaxel in combination with radiation on human head and neck cancer cells (ZMK-1) and cervical squamous cell carcinoma cells (CaSki ).
Pradier O; Rave-Fränk M; Lehmann J; Lücke E; Boghun O; Hess CF; Schmidberger H
Int J Cancer; 2001 Mar; 91(6):840-5. PubMed ID: 11275989
[TBL] [Abstract][Full Text] [Related]
4. Effect of docetaxel on the therapeutic ratio of fractionated radiotherapy in vivo.
Mason KA; Kishi K; Hunter N; Buchmiller L; Akimoto T; Komaki R; Milas L
Clin Cancer Res; 1999 Dec; 5(12):4191-8. PubMed ID: 10632360
[TBL] [Abstract][Full Text] [Related]
5. Experimental study of the effects on apoptosis of docetaxel alone and in combination with irradiation.
Matsuura M; Hasegawa M; Hayakawa K; Kawashima M; Nasu S; Nakamura Y; Hayakawa K; Mitsuhashi N; Niibe H
Oncol Rep; 2000; 7(2):289-93. PubMed ID: 10671673
[TBL] [Abstract][Full Text] [Related]
6. Taxane sensitivity of ovarian carcinoma in vitro.
Engblom P; Rantanen V; Kulmala J; Heiskanen J; Grenman S
Anticancer Res; 1997; 17(4A):2475-9. PubMed ID: 9252666
[TBL] [Abstract][Full Text] [Related]
7. Concentration-dependent radiosensitizing effect of docetaxel in esophageal squamous cell carcinoma cells.
Miyanaga S; Ninomiya I; Tsukada T; Okamoto K; Harada S; Nakanuma S; Sakai S; Makino I; Kinoshita J; Hayashi H; Nakamura K; Oyama K; Nakagawara H; Miyashita T; Tajima H; Takamura H; Fushida S; Ohta T
Int J Oncol; 2016 Feb; 48(2):517-24. PubMed ID: 26676807
[TBL] [Abstract][Full Text] [Related]
8. Differential impact of Raf-1 kinase activity on tumor cell resistance to paclitaxel and docetaxel.
Britten RA; Klein K
Anticancer Drugs; 2000 Jul; 11(6):439-43. PubMed ID: 11001384
[TBL] [Abstract][Full Text] [Related]
9. Interaction of ionizing radiation with paclitaxel (Taxol) and docetaxel (Taxotere) in HeLa and SQ20B cells.
Hennequin C; Giocanti N; Favaudon V
Cancer Res; 1996 Apr; 56(8):1842-50. PubMed ID: 8620502
[TBL] [Abstract][Full Text] [Related]
10. Amifostine protects normal tissues from paclitaxel toxicity while cytotoxicity against tumour cells is maintained.
Taylor CW; Wang LM; List AF; Fernandes D; Paine-Murrieta GD; Johnson CS; Capizzi RL
Eur J Cancer; 1997 Sep; 33(10):1693-8. PubMed ID: 9389935
[TBL] [Abstract][Full Text] [Related]
11. Paclitaxel- and docetaxel-dependent activation of CA-125 expression in human ovarian carcinoma cells.
Marth C; Zeimet AG; Widschwendter M; Ludescher C; Kaern J; Tropé C; Gastl G; Daxenbichler G; Dapunt O
Cancer Res; 1997 Sep; 57(17):3818-22. PubMed ID: 9288793
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxicity of paclitaxel and docetaxel in human neuroblastoma cell lines.
Riccardi A; Servidei T; Tornesello A; Puggioni P; Mastrangelo S; Rumi C; Riccardi R
Eur J Cancer; 1995; 31A(4):494-9. PubMed ID: 7576952
[TBL] [Abstract][Full Text] [Related]
13. In vitro antiproliferative activity of docetaxel (Taxotere), paclitaxel (Taxol) and cisplatin against human tumour and normal bone marrow cells.
Braakhuis BJ; Hill BT; Dietel M; Kelland LR; Aapro MS; Zoli W; Lelieveld P
Anticancer Res; 1994; 14(1A):205-8. PubMed ID: 7909419
[TBL] [Abstract][Full Text] [Related]
14. Comparison of paclitaxel and docetaxel (Taxotere) in gynecologic and breast cancer cell lines with the ATP-cell viability assay.
Untch M; Untch A; Sevin BU; Angioli R; Perras JP; Koechli O; Averette HE
Anticancer Drugs; 1994 Feb; 5(1):24-30. PubMed ID: 7910494
[TBL] [Abstract][Full Text] [Related]
15. In vitro efficacy of a novel chemoradiopotentiator--taxoltere metro.
Yang LX; Wang HJ; Holton RA
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):159-63. PubMed ID: 10656388
[TBL] [Abstract][Full Text] [Related]
16. Low-dose irradiation and short-exposure suboptimal-dose paclitaxel adversely modulate metastatic potential of squamous carcinoma cells.
Lövey J; Fazekas K; Ladányi A; Németh G; Tímár J
Strahlenther Onkol; 2003 Dec; 179(12):812-8. PubMed ID: 14652669
[TBL] [Abstract][Full Text] [Related]
17. Docetaxel enhances tumor radioresponse in vivo.
Mason KA; Hunter NR; Milas M; Abbruzzese JL; Milas L
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2431-8. PubMed ID: 9815644
[TBL] [Abstract][Full Text] [Related]
18. Comparison of 2-methoxyestradiol-induced, docetaxel-induced, and paclitaxel-induced apoptosis in hepatoma cells and its correlation with reactive oxygen species.
Lin HL; Liu TY; Chau GY; Lui WY; Chi CW
Cancer; 2000 Sep; 89(5):983-94. PubMed ID: 10964328
[TBL] [Abstract][Full Text] [Related]
19. Radiobiological effects of docetaxel (Taxotere): a potential radiation sensitizer.
Creane M; Seymour CB; Colucci S; Mothersill C
Int J Radiat Biol; 1999 Jun; 75(6):731-7. PubMed ID: 10405003
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of radiation-induced DNA double-strand breaks and micronuclei in human colon carcinoma cells by N-methylformamide.
Tofilon PJ; Vines CM; Bill CA
Radiat Res; 1989 Jul; 119(1):166-75. PubMed ID: 2756107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
